• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Fisherbrand Sterile Swabs

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
 Class 2 Device Recall Fisherbrand Sterile Swabs see related information
Date Posted August 12, 2013
Recall Status1 Terminated on October 20, 2014
Recall Number Z-1955-2013
Recall Event ID 65822
Product Classification Applicator, absorbent tipped, sterile - Product Code KXG
Product Fisherbrand Sterile Swab, Calcium Alginate Fiber Tipped, Wood Applicator Swab 100 pouches/boxes, 10 boxes/case.

Used in applying medications to or take specimens from a patient.
Code Information Product code # 14-959-81, lot #61513, expiration date: 2014-08, and lot 8710, expiration date 2014-08.
Recalling Firm/
Fisher Scientific Co
300 Industry Dr
Pittsburgh PA 15275-1001
For Additional Information Contact Fisher Scientific Co. Customer Service
Manufacturer Reason
for Recall
The firm is recalling Fisherbrand Sterile Swabs due to 4 customer complaints reporting the presence of non-pathogenic organisms in two lots. The finding was confirmed in lot 61513 and lot 8710 is also being recalled as a precautionary measure.
FDA Determined
Cause 2
Material/Component Contamination
Action Customers were notified by letter on June 18, 2013 and requested to discontinue use and return all affected product. The firm also asked that any additional affected customer base be contacted and notified of the recall if the lots had been further distributed. If you have any questions, contact Stericycle (reference "Event 4070") at 1-877-410-5558.
Quantity in Commerce 1230
Distribution Nationwide and the country of Canada.
Total Product Life Cycle TPLC Device Report

1 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.